LV13141B - Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids - Google Patents
Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids Download PDFInfo
- Publication number
- LV13141B LV13141B LVP-04-02A LV040002A LV13141B LV 13141 B LV13141 B LV 13141B LV 040002 A LV040002 A LV 040002A LV 13141 B LV13141 B LV 13141B
- Authority
- LV
- Latvia
- Prior art keywords
- hydroxy
- alkyl
- compounds
- hiv
- optionally substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4072993A | 1993-03-31 | 1993-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LV13141B true LV13141B (en) | 2004-08-20 |
Family
ID=21912617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-04-02A LV13141B (en) | 1993-03-31 | 2004-01-07 | Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids |
Country Status (35)
| Country | Link |
|---|---|
| EP (1) | EP0617968B1 (xx) |
| JP (1) | JPH08508496A (xx) |
| KR (1) | KR100311551B1 (xx) |
| CN (1) | CN1090186C (xx) |
| AT (1) | ATE230610T1 (xx) |
| AU (1) | AU685772B2 (xx) |
| BG (1) | BG62083B1 (xx) |
| BR (1) | BR9406503A (xx) |
| CA (1) | CA2120192A1 (xx) |
| CY (1) | CY2326B1 (xx) |
| CZ (1) | CZ286412B6 (xx) |
| DE (1) | DE69431972T2 (xx) |
| DK (1) | DK0617968T3 (xx) |
| DZ (1) | DZ1766A1 (xx) |
| ES (1) | ES2188604T3 (xx) |
| FI (1) | FI954580A (xx) |
| HK (1) | HK1009248A1 (xx) |
| HR (1) | HRP940209B1 (xx) |
| HU (1) | HUT74006A (xx) |
| IL (1) | IL109166A (xx) |
| LV (1) | LV13141B (xx) |
| NO (1) | NO953876L (xx) |
| NZ (1) | NZ265164A (xx) |
| PL (1) | PL310895A1 (xx) |
| PT (1) | PT617968E (xx) |
| RO (1) | RO118000B1 (xx) |
| RU (1) | RU2139052C1 (xx) |
| SA (1) | SA94140745B1 (xx) |
| SG (1) | SG64366A1 (xx) |
| SI (1) | SI9420017B (xx) |
| SK (1) | SK279471B6 (xx) |
| TW (1) | TW307684B (xx) |
| WO (1) | WO1994022480A1 (xx) |
| YU (1) | YU49275B (xx) |
| ZA (1) | ZA942255B (xx) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU692509B2 (en) * | 1993-12-15 | 1998-06-11 | Merck & Co., Inc. | HIV protease inhibitors |
| UA49803C2 (uk) * | 1994-06-03 | 2002-10-15 | Дж.Д. Сьорль Енд Ко | Спосіб лікування ретровірусних інфекцій |
| US5476874A (en) * | 1994-06-22 | 1995-12-19 | Merck & Co., Inc. | New HIV protease inhibitors |
| WO1996012492A1 (en) * | 1994-10-25 | 1996-05-02 | Merck & Co., Inc. | Microbial synthesis of hiv protease inhibitors |
| US6689761B1 (en) * | 1995-02-01 | 2004-02-10 | Merck & Co., Inc. | Combination therapy for HIV infection |
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
| US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
| US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| PE11499A1 (es) * | 1997-05-16 | 1999-03-01 | Procter & Gamble | Tratamiento del hiv y cancer |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| HU9701081D0 (en) * | 1997-06-23 | 1997-08-28 | Gene Research Lab Inc N | Pharmaceutical composition of antitumoral activity |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| EP1095022A1 (en) | 1998-07-08 | 2001-05-02 | G.D. Searle & Co. | Retroviral protease inhibitors |
| WO2000021565A1 (en) * | 1998-10-13 | 2000-04-20 | Du Pont Pharmaceuticals Company | Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EP1771169A1 (en) | 2004-07-14 | 2007-04-11 | PTC Therapeutics, Inc. | Methods for treating hepatitis c |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| NZ553329A (en) | 2004-07-22 | 2010-09-30 | Ptc Therapeutics Inc | Thienopyridines for treating hepatitis C |
| RU2520967C1 (ru) * | 2013-02-08 | 2014-06-27 | Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09) |
| CN109528747A (zh) * | 2018-12-13 | 2019-03-29 | 中国人民解放军总医院 | 扎西他滨在制备抗菌消炎药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992021647A1 (en) * | 1991-06-04 | 1992-12-10 | Smithkline Beecham Corporation | Carbocyclic and heterocyclic hiv protease inhibitors |
-
1994
- 1994-03-24 SK SK1225-95A patent/SK279471B6/sk unknown
- 1994-03-24 HU HU9502860A patent/HUT74006A/hu unknown
- 1994-03-24 JP JP6522189A patent/JPH08508496A/ja not_active Ceased
- 1994-03-24 CN CN94191671A patent/CN1090186C/zh not_active Expired - Fee Related
- 1994-03-24 PL PL94310895A patent/PL310895A1/xx unknown
- 1994-03-24 RO RO95-01690A patent/RO118000B1/ro unknown
- 1994-03-24 CZ CZ19952528A patent/CZ286412B6/cs not_active IP Right Cessation
- 1994-03-24 WO PCT/US1994/003209 patent/WO1994022480A1/en active IP Right Grant
- 1994-03-24 RU RU95122135/14A patent/RU2139052C1/ru not_active IP Right Cessation
- 1994-03-24 SI SI9420017A patent/SI9420017B/sl not_active IP Right Cessation
- 1994-03-24 BR BR9406503A patent/BR9406503A/pt not_active Application Discontinuation
- 1994-03-24 NZ NZ265164A patent/NZ265164A/en unknown
- 1994-03-24 KR KR1019950704319A patent/KR100311551B1/ko not_active IP Right Cessation
- 1994-03-28 TW TW083102718A patent/TW307684B/zh active
- 1994-03-29 EP EP94302260A patent/EP0617968B1/en not_active Expired - Lifetime
- 1994-03-29 DK DK94302260T patent/DK0617968T3/da active
- 1994-03-29 AT AT94302260T patent/ATE230610T1/de not_active IP Right Cessation
- 1994-03-29 ES ES94302260T patent/ES2188604T3/es not_active Expired - Lifetime
- 1994-03-29 DE DE69431972T patent/DE69431972T2/de not_active Expired - Fee Related
- 1994-03-29 SG SG1996008650A patent/SG64366A1/en unknown
- 1994-03-29 CA CA002120192A patent/CA2120192A1/en not_active Abandoned
- 1994-03-29 PT PT94302260T patent/PT617968E/pt unknown
- 1994-03-30 HR HR940209A patent/HRP940209B1/xx not_active IP Right Cessation
- 1994-03-30 DZ DZ940030A patent/DZ1766A1/fr active
- 1994-03-30 IL IL10916694A patent/IL109166A/en not_active IP Right Cessation
- 1994-03-30 YU YU15994A patent/YU49275B/sh unknown
- 1994-03-30 ZA ZA942255A patent/ZA942255B/xx unknown
- 1994-03-30 AU AU59213/94A patent/AU685772B2/en not_active Ceased
- 1994-05-31 SA SA94140745A patent/SA94140745B1/ar unknown
-
1995
- 1995-09-20 BG BG100016A patent/BG62083B1/bg unknown
- 1995-09-27 FI FI954580A patent/FI954580A/fi unknown
- 1995-09-29 NO NO953876A patent/NO953876L/no unknown
-
1998
- 1998-08-12 HK HK98109863A patent/HK1009248A1/xx not_active IP Right Cessation
-
2003
- 2003-05-07 CY CY0300041A patent/CY2326B1/xx unknown
-
2004
- 2004-01-07 LV LVP-04-02A patent/LV13141B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV13141B (en) | Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids | |
| AU676563B2 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| EP0541168B1 (en) | HIV protease inhibitors useful for the treatment of aids | |
| CA2178760C (en) | Hiv protease inhibitors | |
| US5650412A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| WO1994026749A1 (en) | Hiv protease inhibitors | |
| US5747540A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| US5811462A (en) | HIV Protease inhibitors useful for the treatment of AIDS | |
| GB2288801A (en) | HIV protease inhibitors useful for the treatment of aids | |
| AU711713B2 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| GB2307683A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| GB2287938A (en) | Conformationally restricted HIV-1 protease inhibitors | |
| CA2375954A1 (en) | Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof |